Experts Provide a New Framework for Systemic Sclerosis Treatment
A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.
A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.
Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.
A possible bidirectional association between migraine and rheumatoid arthritis (RA) is investigated.
The relationship between atherosclerotic cardiovascular disease (CVD) and rheumatoid arthritis (RA) is detailed.
An overview of the history of genome-wide association studies (GWAS) for osteoporosis, and the existing challenges and recent developments in GWAS in the bone field.
Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.
Katherine Wysham, MD, of the VA Puget Sound Health Care System explains how to avoid the use of glucocorticoids and employ screening tools to lessen the risk for osteoporotic fractures in patients with RA.
Several studies have assessed the potentially increased rate and the management of osteoporotic and fragility fractures during the COVID-19 pandemic.
The American College of Rheumatology developed guidelines for the management of gout, including use of urate-lowering therapy, flare treatment, and lifestyle and medication recommendations.
Experts have advised the evaluation of spondyloarthritis in patients with inflammatory bowel disease.